N/A
N=15
Glucose Measurement Using Microneedle Patches
Diabetes
Bottom Line
View on ClinicalTrials.gov: NCT02682056 ↗Enrolled (actual)
15
Serious AEs
0.0%
Results posted
Jan 2020
Primary outcome: Primary: Glucose Level — 137; 174.5; 160.9; 155 mg/dL
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Microneedle patch (Device); Intravenous (IV) catheter (Device); Lancet (Device)
- Age
- Pediatric, Adult · 7+ yrs
- Sex
- All
- Sponsor
- Emory University
- Primary completion
- Jan 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Glucose Level |
137; 174.5; 160.9; 155; 271.4; 227.3 | — |
| SECONDARY Apprehension Level Assessed by Apprehension Visual Analog Scale (VAS) |
24.1; 5.8; 30.8; 12.2; 4.9; 24.4 | — |
| SECONDARY Pain Level Assessed by Pain Visual Analog Scale (VAS) |
22.5; 5.8; 33.4; 11.2; 4.4; 26.8 | — |
Summary
This study will compare three glucose measurement techniques among diabetic children and adolescents. The study seeks to determine if a microneedle patch (made from biocompatible polymers or metal), versus a lancet or intravenous catheter, would be a preferable option for monitoring glucose levels among the diabetic pediatric population.
Eligibility Criteria
Inclusion Criteria
- Diabetes diagnosis
Exclusion Criteria
- no exclusion criteria are specified
Data sourced from ClinicalTrials.gov (NCT02682056). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.